dicarbethoxydihydrocollidine has been researched along with Nerve Degeneration in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, ZC; Guan, JL; Liang, CC; Wang, C; Zhu, Y | 1 |
Fujimoto, M; Gomi, M; Hashimoto, N; Hayase, M; Marumo, T; Masutani, H; Nozaki, K; Takagi, Y; Yodoi, J; Zhou, F | 1 |
2 other study(ies) available for dicarbethoxydihydrocollidine and Nerve Degeneration
Article | Year |
---|---|
FIP200 is required for maintenance and differentiation of postnatal neural stem cells.
Topics: Acetylcysteine; Age Factors; Animals; Animals, Newborn; Apoptosis; Autophagy; Autophagy-Related Proteins; Bromodeoxyuridine; Cell Differentiation; Cerebral Ventricles; Chloroquine; Dentate Gyrus; Dicarbethoxydihydrocollidine; Embryo, Mammalian; Gene Expression Regulation, Developmental; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Mutation; Nerve Degeneration; Neural Cell Adhesion Molecule L1; Neural Stem Cells; Reactive Oxygen Species; Sialic Acids; SOXB1 Transcription Factors; Transcription Factor TFIIH; Transcription Factors; Tumor Suppressor Protein p53 | 2013 |
Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia.
Topics: Analysis of Variance; Animals; Caspase 3; Cell Death; Chromones; Dicarbethoxydihydrocollidine; Disease Models, Animal; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Nerve Degeneration; Proto-Oncogene Proteins c-akt; Stilbamidines; Thioredoxins; Time Factors | 2009 |